What is the best treatment approach for a patient with erythematous macular scars after acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Erythematous Macular Scars After Acne

For erythematous macular acne scars, microneedling combined with platelet-rich fibrin (PRF) or platelet-rich plasma (PRP) is the most effective treatment approach, with PRF demonstrating 3-fold better outcomes than PRP. 1

Primary Treatment Algorithm

First-Line: Microneedling with Autologous Platelet Concentrates

Microneedling combined with PRF is superior to all other modalities for erythematous macular acne scars. 1

  • Treatment protocol: 3 sessions spaced 1 month apart, using 1.5mm needle depth 1
  • PRF preparation: Single spin at 700 rpm for 3 minutes, no anticoagulant required 1
  • Application technique: Apply PRF before microneedling to allow the needling effect to push growth factors into the skin 1
  • Maintenance: One treatment every 6 months after initial series 1

Expected outcomes:

  • 85.4% improvement in scar severity using the Goodman and Baron Scale 1
  • Mean patient satisfaction score of 5.95/7 1
  • Results visible at 24 weeks with mean scar grade reduction from 3.45 to 1.47 1

Alternative: Microneedling with PRP (if PRF unavailable)

  • PRP preparation: Double spin - first at 1500 rpm for 10 minutes, then 3700 rpm for 10 minutes with sodium citrate anticoagulant 1
  • Activation: 10% calcium chloride before application 1
  • Expected outcomes: 82.9% improvement, though significantly less effective than PRF 1

Secondary Treatment Options

Laser Therapy for Persistent Erythema

Pulsed dye laser, neodymium-doped yttrium aluminum garnet (Nd:YAG), and fractional CO2 lasers are highly effective for managing erythematous macular scars. 2

  • These lasers demonstrate "eye-catching capabilities" in managing erythema specifically 2
  • Adverse events are minimal, bearable, and transient 2
  • Critical consideration: Patients with darker skin types require modified protocols to prevent post-inflammatory hyperpigmentation 3

Topical Therapy as Adjunct

Tretinoin 0.025-0.1% applied nightly can improve macular erythema and skin texture. 4

  • Apply once daily before bedtime to affected areas 4
  • Therapeutic results appear after 2-3 weeks, but 6+ weeks may be required for definite benefits 4
  • Sun protection is mandatory - minimize sunlight exposure and use sunscreen over treated areas 4

Azelaic acid 15-20% is particularly valuable for post-inflammatory changes and erythema. 5

  • Works through anti-inflammatory mechanisms while lightening dyspigmentation 5
  • Safer for darker skin tones with less irritation potential 5
  • Pregnancy category B, making it suitable for women of childbearing age 5

Critical Clinical Considerations

Monitoring for Scar Evolution

Erythematous macules are precursors to permanent atrophic scars in 83% of cases. 6

  • Duration of the erythematous phase is a key factor in permanent scar risk 6
  • 81.7% of scars present at 6 months remain at 2-year follow-up 6
  • Clinical implication: Treat erythematous macules aggressively during the first 6 months to prevent permanent scarring 6

Common Pitfalls to Avoid

Never apply PRP/PRF after microneedling - this eliminates the benefit of pushing growth factors into the dermis 1

Do not use topical antibiotics for scar treatment - they have no role in post-inflammatory changes and only contribute to bacterial resistance 5

Avoid using microneedling or laser as monotherapy - combination with autologous platelet concentrates shows significantly better efficacy than single modalities 1, 7

Do not skip sun protection with tretinoin - heightened photosensitivity can worsen erythema and create new post-inflammatory changes 4

Treatment Selection Based on Scar Characteristics

For Fresh Erythematous Macules (<6 months)

  • Start with topical tretinoin + azelaic acid immediately 5, 4
  • Add microneedling with PRF at 1 month if no improvement 1
  • This aggressive early approach prevents 66.2% of transient scars from becoming permanent 6

For Established Erythematous Macular Scars (>6 months)

  • Begin with microneedling + PRF as primary treatment 1
  • Consider adding laser therapy (pulsed dye or Nd:YAG) if erythema persists after 3 PRF sessions 2
  • Continue topical tretinoin and azelaic acid throughout treatment course 5, 4

For Skin of Color Patients

Use lower laser settings and longer intervals between treatments to minimize post-inflammatory hyperpigmentation risk. 3

  • Fractional radiofrequency and microneedling with PRF are safer first-line options 7
  • Azelaic acid is particularly valuable due to its specific lightening effect without causing irritation 5

Realistic Expectations

No treatment eliminates scarring completely, but microneedling with PRF can achieve >85% improvement in appearance. 1, 3

  • Improvement is gradual, with optimal results at 24 weeks 1
  • Multiple treatment sessions are required - single treatments are inadequate 1
  • Maintenance treatments every 6 months sustain improvements 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Laser treatment of acne scarring in skin of colour.

Clinical and experimental dermatology, 2023

Guideline

Treatment of Post-Inflammatory Hyperpigmentation and Acne Scars

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evidence-based Surgical Management of Post-acne Scarring in Skin of Color.

Journal of cutaneous and aesthetic surgery, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.